Relate XR

Enhancing Recovery Treatment

 

Virtual Reality (VR) therapeutics for enhanced clinical outcomes.

Digital Doubles

Digital Doubles allow patients to interact with their life choices visualized through virtual avatars.

Personalized Avatars

Personalized avatars are crafted using advanced AI to resonate deeply with users and enhance engagement.

Future Thinking

Pilot data indicates that personalized avatars activate key brain regions linked to introspection and future thinking, linked to successful recovery outcomes.

Brandon Oberlin, PhD

Brandon Oberlin, PhD

Science

Dr. Brandon Oberlin, Assistant Professor in the Psychiatry Department at Indiana University School of Medicine, brings 20 years of addiction research experience to the team. His work, which includes 26 peer-reviewed publications and five NIH-funded grants, is invaluable to the medical aspect of their projects. Dr. Oberlin’s deep understanding of the neurobehavioral basis of addiction and recovery enriches the team’s ability to innovate and address complex challenges in health and wellness.

Andrew Nelson

Andrew Nelson

Technology

Andrew Nelson, renowned for his expertise in creating immersive learning experiences across XR, web, and mobile platforms, has been at the forefront of virtual and augmented reality technologies since the late 1990s. His leadership at Half Full Nelson has set new industry standards, contributing significantly to the team’s innovative edge.

Izzy Branam

Izzy Branam

Business

Izzy Branam is a young software founder and CEO. Izzy founded Fia Technologies, Inc, a talent acquisition platform that leveraged machine learning to streamline and de-risk hiring decisions, attracting venture capital funding. This accomplishment established Izzy as one of the youngest venture-backed CEOs in the United States, achieving this milestone before graduating high school. Following a stint at Indiana’s leading life science studio and fund, Boomerang Ventures, Izzy joined forces with Dr. Brandon Oberlin and Andrew Nelson to pursue Relate XR.

William T

William T

CTO

Lorem Ipsum is simply dummy text of the printing and typesetting industry. … exact original form, accompanied by English versions from the 1914 translation by. simply dummy text of the printing and typesetting industry

Dorian Jay

Dorian Jay

Copywriter

Lorem Ipsum is simply dummy text of the printing and typesetting industry. … exact original form, accompanied by English versions from the 1914 translation by. simply dummy text of the printing and typesetting industry

Research Collaborators

This research was supported by the National Institutes of Health (NIH) Small Business Technology Transfer (STTR) grant R41DA055405. The content is solely the responsibility of Relate XR and does not necessarily represent the official views of the NIH. Collaborative research efforts do not necessarily indicate endorsement by any listed entity.

Preliminary Studies Ongoing

Relate XR is actively conducting preliminary studies to further refine and validate our virtual reality interventions. These ongoing efforts are crucial as we progress toward FDA clearance, ensuring that our solutions meet rigorous standards of efficacy and safety.

Get In Touch

We Want To Meet You

We eagerly welcome discussions with clinicians, insurance payers, and subject matter experts as we advance towards FDA clearance.

Relate XR

Relate XR’s technology is an investigational device and is not cleared for marketing by the FDA. It is limited by federal law to investigational use. Clinical studies are ongoing.

Copyright © 2024 Relate XR. All Rights Reserved.